. These acute effects of particulate matter particles of 10 pm or less in aerodynamic diameter (PM1) have been observed in children with respiratory symptoms (1, 4, 5) , in children without respiratory symptoms (1) , and in asthmatic patients (2, 5, 4 , but some studies have failed to show consistent associations between particulate air pollution and lung function (9) (10) (11) or any respiratory symptoms (9, 10) during particulate air pollution episodes. These differences in response may be due to differences in the panel characteristics or in the air pollution exposures. Subjects with preexisting chronic respiratory disease are considered to be subgroups of the population that are sensitive for health effects.
Under conditions in which pollutant values are near or below the recommended guidelines, symptomatic children appeared to be the most sensitive subgroup (1,4, whereas studies of asthmatic patients have failed to
show consistent associations (9-14. These latter results were unexpected because most subjects with asthma have hyperreactive airways that respond to nonspecific external stimuli (13) . Howevi experimental studies on young adults wi mild asthma have shown that routinely us asthma medications such as theophylli and beta-agonist were able to attenuate reverse the effects of sulfur dioxide (SO2) lung function (14) (15) (16) (25 January 1992) , the highest PSA concentration (4.8 pg/m3) was detected. This value was confirmed by an independent measurement by a second sampler (20) . The concentrations of SO2 and particle measurements were highly correlated; for example, sulfate (SO4) concentrations were highly correlated with SO2 (r = 0.79) and PM1O (r = 0.80). PMIO was strongly correlated with TSP (r = 0.90) and SO2 (r = 0.75). No data on ozone concentrations were available for Sokolov during the winter of 1991-1992 because of low levels. These analyses are therefore restricted to the effects of particulate and sulfur pollution.
To simplify the presentation in the following section, results are presented only for SO4 as a general indicator of particulate and sulfur pollution. SO4 was previously shown to be the air pollution indicator most strongly and consistently associated with PEF in the larger panel study (6, 8) .
Statistical analysis. Previous analyses of panels of asthmatic subjects have used time-series methods to evaluate the association between the mean day-specific health outcomes and air pollution (6, 8) . In this study, the impact of medication use on subject-specific time series was analyzed with generalized linear models (23, 24) . Models for binary and normally distributed data were estimated with control for a linear trend, 24-hr mean temperature, and weekend (versus weekday). To control for viral infections that may have coincided with high exposures to air pollution at the end of January 1992, additional analyses adjusted for the mean prevalence of fever in the cohort. A detailed analysis of possible confounding of the association between respiratory health and air pollution by viral infections has been published elsewhere (8) .
Missing observations were assumed to be missing completely at random and were omitted. Because repeated measurements were taken on each individual, a variance-covariance structure that took into account that the error-term was associated with the outcome measured on the previous day was considered. Analyses were restricted to the 82 patients who contributed more than 21 observations (average: 76.8 observations) during the period of analysis; 95% confidence intervals were calculated on the basis of robust standard errors. Previous analyses suggested that the strongest associations between health outcomes and air pollution were attributable to the concentrations of sulfate fine partides (8) . SO4 was chosen to present analyses with regard to medication use because it measured the partide fraction attributable to SO2, the major air pollutant of the area. Same-day and 5-day mean (current plus 4 previous days) SO4 was used to compare immediate and delayed impact of air pollutants. In the case of missing exposure data, the mean of the available measurements was taken. Cough induded reporting of cough during the day or cough during the night before. Dyspnea included dyspnea at rest, on exertion, or at night. Beta-agonist and theophylline use were summarized in a binary variable, which was 1 if theophylline or beta-agonist use was recorded. Associations between medication use and symptoms were evaluated by indusion of an indicator for medication in the logistic models with control for a linear trend, 24-hr mean temperature, weekend (versus weekday), and 5-day mean ofSO4.
Results
The cohort of 82 children was divided into those who did (n = 51) or did not (n= 31) use asthma medication during the period 15 November 1991-14 February 1992 (Table 1) . Children who took medication were reported to have a diagnosis of asthma more frequently, but the prevalence of bronchitic symptoms was similar. The medicated children were slightly younger, had lower mean PEF, and reported a higher prevalence of symptoms than nonmedicated children. The prevalence of cough, dyspnea, and phlegm was more than three times higher among medicated children, and they reported fever more frequently and were absent from school more often during the period of analysis than nonmedicated children.
Exacerbation of asthma in 22 children was treated with theophylline only. One child used beta-agonist alone, and eight children used both types of medication. Two of the children were receiving continuous therapy, one with theophylline only and one with theophylline and beta-agonist (Fig. 1) . All other children took asthma medication infrequently as needed. There were shortages of beta-agonist during the whole study period, which might explain the low prevalence of beta-agonist use (rather than a preference for a different approach to asthma therapy). Cortisone Separate analyses for medicated and nonmedicated children were conducted to evaluate differences in response to particulate air pollution. Table 4 for the 5-day mean of S04. Increased symptoms and decreased PEF were strongly associated with increased medication use. All symptoms except runny nose were associated with increased medication use. The children appeared to adjust their medication use according to their perception of their health. The strongest associations were found for dyspnea at night and at rest, which were symptoms indicating an exacerbation of asthma. However, adjustment for medication use did not modify the associations with the 5-day mean S04 concentration (Table 4 compared with Table 3 results) .
Viral infections at the end of January 1992 may have coincided with an episode of particulate air pollution and potentially confounded the association between health outcomes and SO4 exposures (8) . Additional analyses adjusting for the prevalence of fever in the sample were conducted in order to assess possible confounding. The association between the PEF and SO4 was not altered in these additional analyses ( Fig. 2A) . However, associations between phlegm/runny nose and SO4 concentrations were reduced in the nonmedicated children but not in the medicated children after adjustment for fever (Fig. 2B) . The effect estimates for the association between health outcomes and medication use were not confounded by the prevalence of fever.
Discussion
Previous analyses showed decreased PEF rates and increased prevalence of respiratory symptoms and beta-agonist use in association with increased 5-day means of sulfate fine particle concentrations in children with mild asthma from Sokolov, the Czech Republic (6, 8) . Concentrations (8, 20, 21) .
An analysis of these same data for a 3-month period during the winter of [1991] [1992] stratified by medication use, suggested that nonmedicated children (51 panelists) differed substantially from children who took medication (31 panelists) in and health outcomes.
The associations between health outcomes and elevated levels of SO4 may be confounded by coinciding viral infections (25) . In a longitudinal study of children who reported wheezing or persistent cough, exacerbation of symptoms and severe decreases in PEF were, in 80% of the cases, associated with the presence of viruses detected by polymerase chain reaction (26 
